Influence of Pongamia, Mahua and Neem cakes on finger millet productivity and soil fertility

A field experiment conducted at Bio-fuel park, Agricultural Research Station, Madenur, Hassan in Kharif season of 2009 to asses the performance of finger millet (Eleusine coracana L.) under different organic manure treatment consisting of four treatments viz., recommended FYM and NPK through inorganic fertilizers as control, Pongamia, Mahua and Neem cake with 5 replications laid in randomized complete block design. The results revealed that application of recommended FYM along with neem cake equivalent to 100% recommended N performedbetter in respect of finger millet productivity and maintenance of soil fertility followed by recommended FYM with 100% NPK through fertilizers. Nutrient supplementation with different oilcakes proved superior in respect of soil sustainability

Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses

Covaxin/BBV152 is a whole virion inactivated SARS-CoV-2 vaccine. The effect of prime-boost vaccination with Covaxin on systemic immune responses is not known. We investigated the effect of Covaxin on the plasma levels of a wide panel of cytokines and chemokines at baseline (M0) and at months 1 (M1), 2 (M2) and 3 (M3) following prime-boost vaccination in healthy volunteers. Our results demonstrate that Covaxin induces enhanced plasma levels of Type 1 cytokines (IFNγ, IL-2, TNFα), Type 2/regulatory cytokines (IL-4, IL-5, IL-10 and IL-13), Type 17 cytokine (IL-17A), other pro-inflammatory cytokines (IL-6, IL-12, IL-1α, IL-1β) and other cytokines (IL-3 and IL-7) but diminished plasma levels of IL-25, IL-33, GM-CSF and Type 1 IFNs. Covaxin also induced enhanced plasma levels of CC chemokine (CCL4) and CXC chemokines (CXCL1, CXCL2 and CX3CL1) but diminished levels of CXCL10. Covaxin vaccination induces enhanced cytokine and chemokine responses as early as month 1, following prime-boost vaccination, indicating robust activation of innate and adaptive immune responses in vaccine recipients

Diagnosis and Treatment of Neurological and Ischemic Disorders Employing Carbon Nanotube Technology

Extensive research on carbon nanotubes has been conducted due to their excellent physicochemical properties. Based on their outstanding physicochemical properties, carbon nanotubes have the potential to be employed as theranostic tools for neurological pathologies such as Alzheimer’s disease and Parkinson’s disease including ischemic stroke diagnosis and treatment. Stroke is currently regarded as the third root cause of death and the leading source of immobility around the globe. The development and improvement of efficient and effective procedures for central nervous system disease diagnosis and treatment is necessitated. The main aim of this review is to discuss the application of nanotechnology, specifically carbon nanotubes, to the diagnosis and treatment of neurological disorders with an emphasis on ischemic stroke. Areas covered include the conventional current diagnosis and treatment of neurological disorders, as well as a critical review of the application of carbon nanotubes in the diagnosis and treatment of ischemic stroke, covering areas such as functionalization of carbon nanotubes and carbon nanotube-based biosensors. A broad perspective on carbon nanotube stimuli-responsiveness, carbon nanotube toxicity, and commercially available carbon nanotubes is provided. Potential future studies employing carbon nanotubes have been discussed, evaluating their extent of advancement in the diagnosis and treatment of neurological and ischemic disorders

Influence of Malnutrition on Adverse Outcome in Children with Confirmed or Probable Viral Encephalitis: A Prospective Observational Study

to explore the independent predictors of adverse outcome in the patients with confirmed/probable viral encephalitis. The primary outcome variable was the incidence of adverse outcomes defined as death or severe neurological deficit such as loss of speech, motor deficits, behavioural problems, blindness, and cognitive impairment. Patients with confirmed or probable viral encephalitis were classified into two groups based on their -score of weight-for-age as per WHO growth charts. Group I. Patients with confirmed or probable viral encephalitis with weight-for-age (W/A) -scores below −2SD were classified as undernourished. Group II. Patients with confirmed or probable viral encephalitis were classified as having normal nutritional status (weight-for-age -score >−2SD). A total of 114 patients were classified as confirmed or probable viral encephalitis based on detailed investigations. On multivariate logistic regression, undernutrition (adjusted OR: 5.05; 95% CI: 1.92 to 13.44) and requirement of ventilation (adjusted OR: 6.75; 95% CI: 3.63 to 77.34) were independent predictors of adverse outcomes in these patients. Thus, the results from our study highlight that the association between undernutrition and adverse outcome could be extended to the patients with confirmed/probable viral encephalitis

Assessment of Economic Impacts of MGNREGA in Selected Two Villages of Karnataka State using Social Accounting Matrix (SAM),Socioeconomics Discussion Paper Series Number 26

Public investment on rural infrastructure development, as done under employment Guarantee Act (MGNREGA), besides providing income, employment and livelihood security to rural labor force, is expected to have positive impacts on other sectors of the rural economy as well. This includes benefit to both farm and non-farm of the rural economy. Therefore, using framework of local economy wide modeling, particularly Social Accounting Matrix (SAM), we have analyzed direct and total economy wide impact of MGNREGA in two different dryland villages of Karnataka state of India: One village is in Tumkur district (Belladamadugu village) in Southern region and the other in Bijapur district (Markabinahalli village) in Northern region of Karnataka. SAM analysis was carried out collecting both primary as well as secondary data for the agricultural year 2012-13 (From 1st June 2012 to 31st May 2013). Purposive sampling was done for collection of data from the households. Following ICRISAT VDSA Study criteria, farm households were classified into five strata namely, landless households, and marginal, small, medium and large land holding households; and farming sector data were collected from the stratified random sampling of these households. In additions, data was collected from different economic agents including shops (Agricultural input shop, canteen, Provision store) and service providers (tailor, barber, drivers, labourers and so on) regarding details of employment provided, receipts and expenditure. Then, we have constructed SAM of 82X82 sizes for the analysis. Multiplier effect of MNGREGS on the whole village economy of Markabinahalli and BM villages was 1.9 and 1.45, respectively. This suggests for a very weak multiplier impact of the MGNREGA interventions. Likewise, we have also estimated income, output and employment multiplier of the MGNREGA interventions in each of the village. On the whole, the direct and total impact of MGNREGS on village economy was weak due to several factors, among them the important factors were the high level of leakage of MGNREGA expenditure on several materials and machines use that were brought from outside of the village economy. At the end, this study also suggests policy measures for enhancing multiplier impact of the MGNREGS program interventions in the local economy

Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concern

BACKGROUND: Covaxin/BBV152 is one of the most widely used vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and one of the few vaccines used extensively in low- and middle-income countries (LMIC). METHODS: We investigated the effect of Covaxin on the SARS-CoV-2 specific IgG and IgA and neutralizing antibody (NAb) levels at baseline (M0) and at Months 1 (M1), 2 (M2), 3 (M3), 4 (M4), 6 (M6) and 12 (M12) following vaccination in healthcare workers. In addition, we also examined the NAb levels against variant lineages of B.1.617.2 (Delta, India), B.1.617.2.1 (Delta Plus, India), B.1.351 (Beta, SA), B.1.1.7 (Alpha, UK) and B.1.1.529 (Omicron). RESULTS: Covaxin induces enhanced SARS-CoV-2 binding antibodies of IgG and IgA responses against both spike (S) and nucleocapsid (N) antigens at M1, M2, M3, M4, M6 and M12 in comparison with M0. Our data also reveal that NAb levels against the ancestral strain (Wuhan, wild type) are elevated and sustained at M1, M2, M3, M4, M6 and M12 in comparison with M0 and against variant lineages of B.1.617.2 (Delta, India), B.1.617.2.1 (Delta Plus, India), B.1.351 (Beta, SA) and B.1.1.7 (Alpha, UK) are elevated at M3, M6 and M12 in comparison with M0. However, NAb levels against B.1.1.529 (Omicron) was consistently below the limit of detection except at M12. CONCLUSION: Thus, Covaxin induces an enhanced humoral immune response, with persistence till at least 12 months post-vaccination against most SARS-CoV-2 variants

Identification of novel resistant sources for ascochyta blight (Ascochyta rabiei) in chickpea

Chickpea (Cicer arietinum L.) is the second largest pulse crop grown worldwide and ascochyta blight caused by Ascochyta rabiei (Pass.) Labr. is the most devastating disease of the crop in all chickpea growing areas across the continents. The pathogen A. rabiei is highly variable. The resistant sources available are not sufficient and new sources needs to be identified from time to time as resistance breakdown in existing chickpea varieties is very frequent due to fast evolution of new pathotypes of the pathogen. Therefore, this work was undertaken to evaluate the existing chickpea germplasm diversity conserved in Indian National Genebank against the disease under artificial epiphytotic conditions. An artificial standard inoculation procedure was followed for uniform spread of the pathogen. During the last five winter seasons from 2014–15 to 2018–19, a total of 1,970 accessions have been screened against the disease and promising accessions were identified and validated. Screening has resulted in identification of some promising chickpea accessions such as IC275447, IC117744, EC267301, IC248147 and EC220109 which have shown the disease resistance (disease severity score �3) in multiple seasons and locations. Promising accessions can serve as the potential donors in chickpea improvement programs. The frequency of resistant and moderately resistant type accessions was comparatively higher in accessions originated from Southwest Asian countries particularly Iran and Syria than the accessions originated from Indian sub-continent. Further large scale screening of chickpea germplasm originated from Southwest Asia may result in identifying new resistant sources for the disease